Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance
Clinical trial NCT07585331 · COMPLETED
Trial details
- NCT number
- NCT07585331
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-13
- Primary completion
- 2026-03-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.